Correlation Between Symtek Automation and GeneFerm Biotechnology

Can any of the company-specific risk be diversified away by investing in both Symtek Automation and GeneFerm Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Symtek Automation and GeneFerm Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Symtek Automation Asia and GeneFerm Biotechnology Co, you can compare the effects of market volatilities on Symtek Automation and GeneFerm Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Symtek Automation with a short position of GeneFerm Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Symtek Automation and GeneFerm Biotechnology.

Diversification Opportunities for Symtek Automation and GeneFerm Biotechnology

0.74

Correlation Coefficient

Symtek Automation  GeneFerm Biotechnology

Poor diversification

The 3 months correlation between Symtek and GeneFerm is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Symtek Automation Asia and GeneFerm Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneFerm Biotechnology and Symtek Automation is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Symtek Automation Asia are associated (or correlated) with GeneFerm Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneFerm Biotechnology has no effect on the direction of Symtek Automation i.e., Symtek Automation and GeneFerm Biotechnology go up and down completely randomly.

Pair Corralation between Symtek Automation and GeneFerm Biotechnology

Assuming the 90 days trading horizon Symtek Automation Asia is expected to generate 2.24 times more return on investment than GeneFerm Biotechnology. However, Symtek Automation is 2.24 times more volatile than GeneFerm Biotechnology Co. It trades about 0.2 of its potential returns per unit of risk. GeneFerm Biotechnology Co is currently generating about 0.08 per unit of risk. If you would invest  12,479  in Symtek Automation Asia on September 12, 2024 and sell it today you would earn a total of  6,721  from holding Symtek Automation Asia or generate 53.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Symtek Automation Asia  vs.  GeneFerm Biotechnology Co

Symtek Automation Asia

Risk-Adjusted Performance

15 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Symtek Automation Asia are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Symtek Automation showed solid returns over the last few months and may actually be approaching a breakup point.

GeneFerm Biotechnology

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, GeneFerm Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Symtek Automation and GeneFerm Biotechnology

The main advantage of trading using opposite Symtek Automation and GeneFerm Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Symtek Automation position performs unexpectedly, GeneFerm Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will offset losses from the drop in GeneFerm Biotechnology's long position.

The idea behind Symtek Automation Asia and GeneFerm Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.